Novel mechanisms involving complement cascade in stem cell trafficking
Novel mechanisms involving complement cascade in stem cell trafficking
批准号:
9529361
负责人:
Mariusz Z Ratajczak
金额:
$34.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-01 至 2021-06-30
关键词:
AddressAlternative Complement PathwayAnimal ModelAntibodiesBlood CirculationBlood VesselsBone MarrowBone Marrow TransplantationCXCR4 ReceptorsCXCR4 geneCell Adhesion MoleculesCell physiologyCellsChemotactic FactorsCircadian RhythmsCoagulation ProcessComplementComplement 1qComplement 3 ConvertaseComplement ActivationComplement Factor HDataDefectDevelopmentDistalElementsEngraftmentEnzymesGenerationsGrowth FactorHematopoiesisHematopoieticHematopoietic Stem Cell MobilizationHematopoietic Stem Cell TransplantationHematopoietic stem cellsHomingImmunoglobulin MIntegrin alpha4beta1IntegrinsLigandsMannose Binding LectinMediatingMolecularMusNatural ImmunityNitric OxideNitric Oxide SynthasePathway interactionsPatientsPatternPattern recognition receptorPharmacologyPhasePhysiologicalPlayProcessProperdinProtocols documentationReportingResearchRoleStem cellsStressTestingThrombinTranslatingTransplantationVascular Cell Adhesion Molecule-1antigen bindingbasecell motilityconditioninggranulocyteheme oxygenase-1leukemiamannose-binding protein-associated serine proteasesmonocyteneoantigensnovelnovel therapeuticsperipheral bloodpre-clinicalpublic health relevancereconstitutionsmall molecule inhibitortrafficking
中文摘要
修改的项目摘要/摘要部分
英文摘要
Modified Project Summary/Abstract Section
The main hypothesis of this competing renewal is based on new exciting data that further supports the pivotal
role of the complement cascade (ComC) and other elements of innate immunity in the mobilization of
hematopoietic stem/progenitor cells (HSPCs). The ComC is activated by the i) classical, ii) mannan-binding
lectin (Mbl), and iii) alternative pathways, and, as we already reported, mice that lack the common distal
component of the ComC (C5–/– mice), are poor mobilizers. To our surprise, however, we found that mice that
do not activate the classical ComC (C1q–/– mice) are normal mobilizers. This “discrepancy” is now explained by
our latest results that show the pivotal involvement of the Mbl-dependent ComC pathway and not the classical
pathway in mobilization. We also recently found that two stress-induced enzymes, heme oxygenase 1 (HO-1)
and inducible nitric oxide synthetase (iNOS), are negative regulators of cell migration. Based on these findings,
we have assembled a proposal that, in a comprehensive way, addresses the involvement of elements of innate
immunity (ComC, Gr-1+ granulocytes/monocytes, naturally occurring antibodies) in the mobilization of HSPCs.
In three interrelated specific aims, we address the crucial: i) inititation, ii) amplification, and execution phases of
mobilization. Specific Aim 1. The initiation phase of mobilization is explained by Mbl-mediated ComC
activation. We have maintained that the classical ComC activation pathway plays a crucial role in triggering
mobilization. However, as we discovered recently, it is not the classical but the Mbl pathway that is crucial in
this process. The main target cells for mobilizing agents are Gr-1+ cells, which, in addition to proteolytic and
lipolytic enzymes, also secrete ROS and danger-associated molecular pattern molecules (DAMPs). While
proteolyic and lipolytic enzymes perturb the retention of HSPCs in bone marrow (BM) niches, ROS-exposed
neoepitope antigens bound by naturally occurring IgM antibodies and DAMPs released from Gr-1+ cells are
recognized by the circulating pattern recognition receptor (PRR) Mbl, which, via mannan-binding lectin serine
proteases (MASPs), activates the ComC and coagulation cascade (CoaC). Specific Aim 2. The amplification
phase of mobilization - the generation of C5 convertase. Since C5 cleavage is crucial for egress of HSPCs
from BM, the main function of this phase is generation of C5 convertase activity. This enzyme is generated as
a result of C3 cleavage, which provides elements of classical C5 convertase, and additionally by thrombin,
which has C5 “convertase-like” activity. The amplification phase is also modulated by a spontaneous
amplification loop of C3 activation and by possible involvement of an alternative pathway of ComC activation
and will be studied in detail in this aim. Specific Aim 3. Execution phase of ComC-mediated mobilization.
Our recent results show that egress of HSPCs from BM is negatively controlled by HO-1 and iNOS, which are
negative regulators of cell migration. We will focus on the molecular mechanisms of this phenomenon. It is
expected that these results will be translated into the development of better mobilization protocols.
1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOACTIVE LIPIDS IN STEM CELL HOMING AND MOBILIZATION
-
批准号:8478688
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2013
-
负责人:Mariusz Z Ratajczak
-
依托单位:
BIOACTIVE LIPIDS IN STEM CELL HOMING AND MOBILIZATION
-
批准号:8826166
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2013
-
负责人:Mariusz Z Ratajczak
-
依托单位:
BIOACTIVE LIPIDS IN STEM CELL HOMING AND MOBILIZATION
-
批准号:8666588
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2013
-
负责人:Mariusz Z Ratajczak
-
依托单位:
Novel hematopoietic effects of C3 cleavage fragments
-
批准号:7211074
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2007
-
负责人:Mariusz Z Ratajczak
-
依托单位:
Novel mechanisms involving complement cascade in stem cell trafficking
-
批准号:9750758
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2007
-
负责人:Mariusz Z Ratajczak
-
依托单位:
Novel hematopoietic effects of C5 cleavage fragment
-
批准号:8431861
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2007
-
负责人:Mariusz Z Ratajczak
-
依托单位:
Novel hematopoietic effects of C3 cleavage fragments
-
批准号:7579931
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2007
-
负责人:Mariusz Z Ratajczak
-
依托单位:
Novel hematopoietic effects of C3 cleavage fragments
-
批准号:7364165
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2007
-
负责人:Mariusz Z Ratajczak
-
依托单位:
Novel hematopoietic effects of C3 cleavage fragments
-
批准号:8034778
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2007
-
负责人:Mariusz Z Ratajczak
-
依托单位:
Novel hematopoietic effects of C5 cleavage fragment
-
批准号:8628110
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2007
-
负责人:Mariusz Z Ratajczak
-
依托单位:
Novel mechanisms involving complement cascade in stem cell trafficking
-
批准号:9397734
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2007
-
负责人:Mariusz Z Ratajczak
-
依托单位:
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma
-
批准号:7454183
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2005
-
负责人:Mariusz Z Ratajczak
-
依托单位:
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma
-
批准号:6965904
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2005
-
负责人:Mariusz Z Ratajczak
-
依托单位:
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma
-
批准号:7124219
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2005
-
负责人:Mariusz Z Ratajczak
-
依托单位:
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma
-
批准号:7257235
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2005
-
负责人:Mariusz Z Ratajczak
-
依托单位:
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma
-
批准号:7632129
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2005
-
负责人:Mariusz Z Ratajczak
-
依托单位:
CORE--MURINE AND HUMAN STEM CELL
-
批准号:6574776
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2002
-
负责人:Mariusz Z Ratajczak
-
依托单位:
CORE--MURINE AND HUMAN STEM CELL
-
批准号:6443869
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2001
-
负责人:Mariusz Z Ratajczak
-
依托单位:
CORE--MURINE AND HUMAN STEM CELL
-
批准号:6301160
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2000
-
负责人:Mariusz Z Ratajczak
-
依托单位:
CORE--MURINE AND HUMAN STEM CELL
-
批准号:6105768
-
项目类别:
-
资助金额:$17.54万
-
财政年份:1999
-
负责人:Mariusz Z Ratajczak
-
依托单位:
海外基金